美國的經由鼻子服用的藥物市場

美國的經由鼻子服用的藥物市場 是由出版商Frost & Sullivan在2006年03月所出版的。 這份英文市場調查報告書價格從美金6000起跳。

簡介

專門從事高科技領域顧問服務及市場調查的美國調查公司 Frost & Sullivan （總公司：德州），針對美國的經由鼻子服用的藥物市場進行詳盡的調查分析， 並整理出版調查報告書 "U.S. Intranasal Drug Delivery Market"

本報告書內容包括：過敏、骨質疏鬆症、疼痛管理、疫苗、性功能不健全等各市場中經由鼻服用藥物的銷售管道分析、未來預測、技術簡介等。 內容綱要摘記如下：

第1章 實施概要

第2章 市場簡介

• 調查範圍與方法論
  • 範圍與區隔
  • 方法論
• 市場簡介
  • 市場工程衡量
  • 技術性簡介
  • 治療目標疾病及應用
  • 課題與策略
  • 市場發展因素

第3章　競爭分析

• 未來預測與趨勢
  • 收益預測
  • 過敏
  • 疼痛管理
  • 骨質疏鬆症
  • 疫苗
  • 性功能不健全
  • 執照與聯盟策略
• 競爭分析
  • 競爭結構
  • 市場佔有率分析
  • 產品分析：過敏
  • 產品分析：偏頭痛
  • 產品分析：骨質疏鬆症
  • 產品分析：疫苗
  • 產品分析：其他
  • 管道分析

第4章　Frost & Sullivan Awards

• Frost & Sullivan Awards
  • Company of the Year Award
  • Entrepreneurial Company of the Year Award
  • Business Development Strategy of the Year Award

第5章 附錄

• 決策支援資料庫
  • 帕金森症的罹患率
  • 老人痴呆症的罹患率
  • 癲癇症的罹患率
  • 氣喘的罹患率
  • 藥品研發（ R&D ）費用

目錄

Abstract

Research Overview

This Frost & Sullivan research service entitled U.S. Intranasal Drug Delivery Market provides pipeline analysis, forecasts and technology overviews. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: allergy, osteoporosis, pain management, vaccines and sexual dysfunction.

This analysis is available through our Pharmaceutical Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils. For more information on this custom subscription service, please click here.

What's Included

• �EPipeline Analysis
• �EMarket Forecasts
• �ETechnology Overviews

Market Sectors

�EAllergy �EPain Management �EOsteoporosis �EVaccines �ESexual Dysfunction

Market Overview

The intranasal drug delivery market is undergoing a fundamental change, shifting from topical to systemic delivered drugs. The last several years have seen allergy corticosteroids dominate the intranasal delivery market but new products in pain management, osteoporosis, vaccines and sexual dysfunction are expected to drive growth and prove systemic drug delivery is the future of revenue generation for this market. New drug delivery technologies and devices are paving the way for peptides and large molecules to be delivered via the nose.

The intranasal drug delivery market is expected to expand the current offerings of drugs in key disease areas such as pain management and osteoporosis. Reformulation of injection and oral drugs is expected to drive these markets forward be offering an enhanced delivery method with fast onset of action. The sexual dysfunction market is expected to bring in substantial revenue as a first in class drug offering a choice for those suffering from sexual dysfunction in both males and females.

Table of Contents

• 1. Executive Summary
  • 1.Exicutive Summery
    • 1. Executive Summary
• 2. Market Introduction
  • 1. Research Scope and Methodology
    • 1. Scope and Segmentation
    • 2. Methodology
  • 2. Market Overview
    • 1. Market Engineering Measurements
    • 2. Technology Overview
    • 3. Disease Targets and Applications
    • 4. Challenges and Strategies
    • 5. Market Drivers
• 3. Competitive Analysis
  • 1. Forecasts and Trends
    • 1. Revenue Forecasts
    • 2. Allergy
    • 3. Pain Management
    • 4. Osteoporosis
    • 5. Vaccines
    • 6. Sexual Dysfunction
    • 7. Licensing and Partnership Strategies
  • 2. Competitive Analysis
    • 1. Competitive Structure
    • 2. Market Share Analysis
    • 3. Product Analysis - Allergy
    • 4. Product Analysis - Migraine
    • 5. Product Analysis - Osteoporosis
    • 6. Product Analysis - Vaccine
    • 7. Product Analysis - Other
    • 8. Pipeline Analysis</p>
• 4. Frost &amp; Sullivan Awards
  • 1. Frost &amp; Sullivan Awards
    • 1. Company of the Year Award
    • 2. Entrepreneurial Company of the Year Award
    • 3. Business Development Strategy of the Year Award</p>
• 5. Appendix
  • 1. Decision Support Databases
    • 1. Prevalence of Parkinson's Disease
    • 2. Prevalence of Alzheimer's Disease
    • 3. Prevalence of Epilepsy
    • 4. Prevalence of Asthma
    • 5. Pharmaceutical R&amp;D Expenditure
• List of Figures
  • SEGMENT 2
    • Intranasal Drug Delivery Market: Major Device and Formulation Companies (U.S.), 2005
    • Intranasal Drug Delivery Market: Impact of Top Industry Challenges (U.S.), 2006-2012
    • Intranasal Drug Delivery Market: Market Drivers Ranked in Order of Impact (U.S.), 2006-2012
  • SEGMENT 3
    • Intranasal Drug Delivery Market: Revenue Forecasts (U.S.), 2002-2012
    • Intranasal Drug Delivery Market: Market Share by Indication (U.S.), 2005
    • Intranasal Drug Delivery Market: Market Share by Indication (U.S.), 2012
    • Intranasal Drug Delivery Market: Market Share by Systemic versus Non-Systemic Delivery(U.S.), 2005
    • Intranasal Drug Delivery Market: Market Share by Systemic versus Non-Systemic Delivery (U.S.), 2012
    • Intranasal Drug Delivery Market: Allergy Revenue Forecasts (U.S.), 2002-2012
    • Intranasal Drug Delivery Market: Pain Management Revenue Forecasts (U.S.), 2002-2012
    • Intranasal Drug Delivery Market: Osteoporosis Revenue Forecasts (U.S.), 2002-2012
    • Intranasal Drug Delivery Market: Vaccine Revenue Forecasts (U.S.), 2002-2012
    • Intranasal Drug Delivery Market: Sexual Dysfunction Revenue Forecasts (U.S.), 2002-2012
    • Intranasal Drug Delivery Market: Five Questions to Asses Licensing/Partnership Strategies (U.S.), 2005
    • Intranasal Drug Delivery Market: Competitive Structure (U.S.), 2005
    • Intranasal Drug Delivery Market: Company Market Share by Revenues (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - Astelin (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - Flonase (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - Nasacort AQ (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - Nasonex (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - Rhinocort Aqua (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - Imitrex (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - Migranal (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - Zomig (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - Fortical (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - Miacalcin (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - fluMist (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - Nascobal (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - Butorphanol (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - Minirin (U.S.), 2005
    • Intranasal Drug Delivery Market: Product Analysis - Stimate (U.S.), 2005
    • Intranasal Drug Delivery Market: Pipeline Overview (U.S.), 2005

相關商品

DDS相關市場調查報告書

胰島素給藥設備:全球開發平台分析機會評估及與到2017年為止的市場預測
Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
價格 : US $ 3995
出版日期 : 2012年01月

經皮藥物給藥：技術・市場・企業
Transdermal Drug Delivery - Technologies, Markets, and Companies
價格 : US $ 3000
出版日期 : 2012年01月

癌症相關之藥物傳輸：技術、市場、企業
Drug Delivery in Cancer - technologies, markets and companies
價格 : US $ 4000
出版日期 : 2012年01月

Frost & Sullivan發行的製藥相關市場調查報告書

歐洲的血栓治療市場分析

Analysis of the European Thrombosis Therapeutics Market

價格 : US $ 6500

出版日期 : 2011年12月

全球學名藥市場

Generic Pharmaceuticals Market - A Global Analysis

價格 : US $ 6500

出版日期 : 2011年12月

歐洲的生物後續品市場的分析

Analysis of European Biosimilars Market

價格 : US $ 6500

出版日期 : 2011年12月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!